Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas-Reference-Cited by-同舟云学术

Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas

Published:2023-12-27 Issue: Volume: Page:
ISSN:1536-1632
Container-title:Molecular Imaging and Biology
language:en
Short-container-title:Mol Imaging Biol

Author:

Streeter Samuel S.^ORCID,Xu Xiaochun,Hebert Kendra A.,Werth Paul M.,Hoopes P. Jack,Jarvis Lesley A.,Pogue Brian W.,Paulsen Keith D.,Samkoe Kimberley S.,Henderson Eric R.

Funder

National Institute of Biomedical Imaging and Bioengineering

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11307-023-01884-9.pdf

Reference41 articles.

1. Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) (2013) WHO classification of tumours of soft tissue and bone. 4th edn., vol. 5. Lyon, IARC Press

2. Pasquali S, Gronchi A (2017) Neoadjuvant chemotherapy in soft tissue sarcomas: Latest evidence and clinical implications. Ther Adv Med Oncol 9:415–429. https://doi.org/10.1177/1758834017705588

3. Bowden L, Booher RJ, Peabody TD, Mindell ER (2004) The classic: The principles and technique of resection of soft parts for sarcoma. Clin Orthop Relat Res 1976–2007:426

4. Kawaguchi N, Ahmed AR, Matsumoto S et al (2004) The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419:165–172. https://doi.org/10.1097/00003086-200402000-00027

5. O’Donnell PW, Griffin AM, Eward WC et al (2014) The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer 120:2866–2875. https://doi.org/10.1002/cncr.28793